Stock BRIACELL THERAPEUTICS CORP
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Briacell Therapeutics Corp Toronto S.E.

Equities

CA10778Y1043

Chart calendar Briacell Therapeutics Corp

fcf2d11fb59b45c810.kZGbq-6V3MAjMgJRbUG6_QLRrErfqSF4WzduL-VvcA8.2fPLnq3-i6VBXjoJOnftrEeQ4D7ozE0PagUKRJIlPUakxtTYrKSkjldBTw~2d7a8a885b832bc12b9b012e010f1426

Upcoming events on Briacell Therapeutics Corp

2024-06-02 10:00 am American Society of Clinical Oncology Annual Meeting - Abstract No : TPS1137
2024-06-02 10:00 am American Society of Clinical Oncology Annual Meeting - Abstract No : 1087
2024-06-03 12:30 pm American Society of Clinical Oncology Annual Meeting - Abstract No : 1022
2024-10-23 Q4 2024 Earnings Release (Projected)
2024-12-10 Q1 2025 Earnings Release (Projected)
2025-03-26 Q2 2025 Earnings Release (Projected)
2025-12-09 Q1 2026 Earnings Release (Projected)

Past events on Briacell Therapeutics Corp

2024-04-10 12:00 pm American Association for Cancer Research Meeting - Abstract No:6753
2024-04-09 12:00 pm American Association for Cancer Research Meeting - Abstract No:CT204
2024-04-09 12:00 pm American Association for Cancer Research Meeting - Abstract No:CT206
2024-03-18 05:05 pm Q2 2024 Earnings Release
2024-01-30 10:00 am Annual General Meeting
2023-12-14 05:10 pm Q1 2024 Earnings Release
2023-12-07 01:00 pm San Antonio Breast Cancer Symposium
2023-12-06 06:00 pm San Antonio Breast Cancer Symposium
2023-12-06 01:00 pm San Antonio Breast Cancer Symposium
2023-11-03 12:00 pm Society for Immunotherapy of Cancer Meeting - Abstract Number: 419
2023-10-26 10:00 am Investor Meeting - Key Opinion Leader
2023-10-25 12:00 pm Q4 2023 Earnings Release
2023-09-04 Spin off
2023-08-18 10:00 am Extraordinary Shareholders Meeting - Restructuring Vote
2023-04-17 01:30 pm American Association for Cancer Research Meeting - Abstract Number: CT143
2023-04-17 09:00 am American Association for Cancer Research Meeting - Abstract Number: 2310
2023-04-17 09:00 am American Association for Cancer Research Meeting - Abstract Number: 2310
2023-04-16 01:30 pm American Association for Cancer Research Meeting - Abstract Number: 685
2023-04-16 01:30 pm American Association for Cancer Research Meeting - Abstract Number: 685
2023-04-16 01:30 pm American Association for Cancer Research Meeting - Abstract Number: 304

Annual results

Fiscal PeriodJulio 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		0,00


-15,3
-15,7
2.58%		-23,3
-21,9
-6.06%
-34,4

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


-26,8
-15,7
-70.86%		-20,3
-24,2
15.94%
-24,5

Net income
Million USD		Released
Forecast
Spread 		-0,43


-26,8
-15,7
-70.86%		-20,3
-24,2
15.94%
-24,5

EPS
USD		Released
Forecast
Spread 		-0,09


-1,73
-1,02
-69.61%		-1,30
-1,56
16.4%
-1,39

Announcement Date28/10/2127/10/2225/10/23-

Quarterly results

Fiscal PeriodJulio 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-3,93
-2,40
-63.85%		-4,84
-3,31
-46.43%		-4,23
-4,61
8.38%		-5,40
-5,20
-3.91%		-4,49
-5,46
17.87%		-5,68
-5,57
-1.97%		-7,71
-6,36
-21.16%		-8,50
-8,00
-6.29%		-9,83
-8,40
-17.02%
-7,90


-8,20

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-3,87
-2,45
-57.76%		-4,84
-3,31
-46.43%		-15,7
-4,61
-241.42%		-1,11
-5,20
78.72%		-11,9
-5,46
-117.52%		-4,90
-5,47
10.46%		-2,42
-6,26
61.36%		5,96
-2,80
312.82%		-11,3
-3,20
-254.18%
-9,40


-9,70

Net income
Million USD		Released
Forecast
Spread 		-3,87
-2,45
-57.76%		-4,84
-3,31
-46.43%		-15,7
-4,61
-241.42%		-1,11
-5,20
78.72%		-11,9
-5,46
-117.52%		-4,90
-5,47
10.46%		-2,42
-6,26
61.36%		6,00
-2,80
314.34%		-11,3
-3,20
-252.96%
-9,40


-9,70

EPS
USD		Released
Forecast
Spread 		-0,24
-0,17
-45.45%		-0,32
-0,21
-52.38%		-1,02
-0,31
-234.43%		-0,07
-0,33
78.79%		-0,77
-0,36
-116.9%		-0,32
-0,36
9.86%		-0,14
-0,40
64.56%		0,36
-0,18
300%		-0,71
-0,20
-255%
-0,55


-0,46

Announcement Date14/03/2213/06/2227/10/2214/12/2215/03/2314/06/2325/10/2314/12/2318/03/24--

Upcoming sector events for Briacell Therapeutics Corp

2024-07-23 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-24 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-25 01:00 am ARGENX SE: Q2 2024 Earnings Release
2024-07-29 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Briacell Therapeutics Corp

2024-05-17 07:00 am AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
2024-05-16 07:46 am BIOCON LIMITED: Q4 2024 Earnings Release
2024-05-16 01:00 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
2024-05-15 08:05 am THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 am CABALETTA BIO, INC.: Q1 2024 Earnings Release
2024-05-14 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
2024-05-15 04:01 pm CELCUITY INC.: Q1 2024 Earnings Release
2024-05-14 04:05 pm ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 04:00 pm ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 08:00 am IMMUNOME, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. BCT Stock
  4. Stock
  5. Calendar Briacell Therapeutics Corp
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW